THAR (THAR)
Tharimmune, Inc.
NASDAQ:THARHealthcare · Biotechnology
Mkt Cap-
Float28.9M
O/S-
Inst Own-
Dilution
MCap-
Float28.9M
O/S-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$35.92M
Total Assets$519.15M
Free Cash Flow-$16.13M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$397.93M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
- 1:15Reverse splitMay 28, 202415 shares → 1
- 1:25Reverse splitNov 21, 202325 shares → 1
Balance Sheet Details
Assets$519.15M
Liabilities$121.22M
Accounts Receivable$0
Accounts Payable$1.09M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$501.76M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | - | - | - | - | - | - | - |
| Research and Development | $3.07M | $6.39M | $3.56M | $2.28M | $1.84M | $847K | $369K |
| Selling, General, and Administrative | $17.03M | $6.04M | $5.9M | $4.6M | $1.37M | $672K | $626K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $20.11M | $12.43M | $9.46M | $6.88M | $3.21M | $1.52M | $995K |
| Operating Income (EBIT) | -$20.11M | -$12.43M | -$9.46M | -$6.88M | -$3.21M | -$1.52M | -$995K |
| Operating Margin | - | - | - | - | - | - | - |
| Interest Expense | $28K | $14K | $17K | $1.59M | $831K | $247K | $75K |
| Interest Income | $41K | $250K | $153K | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$22M | $236K | $136K | -$1.59M | $1M | -$898K | -$531K |
| Income Before Tax (EBT) | -$42.1M | -$12.2M | -$9.32M | -$8.47M | -$2.21M | -$2.42M | -$1.53M |
| Income Tax Expense | -$6.19M | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$35.92M | -$12.2M | -$9.32M | -$8.47M | -$2.21M | -$2.42M | -$1.53M |
| Net Income Margin | - | - | - | - | - | - | - |
| Supplementary Data | |||||||
| EPS | -1.12 | -9.41 | -107.08 | -280.77 | -72.81 | -88.05 | -55.56 |
| Diluted EPS | -1.12 | -9.41 | -107.08 | -280.77 | -72.81 | -88.05 | -55.56 |
| Weighted Average OS | 32.05M | 1.30M | 87,029 | 30,178 | 30,305 | 27,454 | 27,454 |
| EBITDA | -$42.05M | -$12.21M | -$9.15M | -$6.65M | -$1.38M | -$2.17M | -$1.45M |
| EBITDA Margin | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $17.03M | $3.56M | $10.94M | $6.51M | $4K | $192K | $38K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $17.03M | $3.56M | $10.94M | $6.51M | $4K | $192K | $38K |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $353K | $162K | $11K | $178K | $547K | $0 | $0 |
| Total Current Assets | $17.39M | $3.72M | $10.95M | $6.69M | $622K | $295K | $41K |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $501.76M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $501.76M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $519.15M | $3.72M | $10.95M | $6.69M | $622K | $295K | $41K |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $1.09M | $1.09M | $909K | $955K | $1.46M | $515K | $241K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $1.39M | $563K | $431K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $1.32M | $0 | $0 | $980K | $1.33M | $126K |
| Total Current Liabilities | $3.29M | $2.41M | $1.82M | $1.14M | $4.53M | $2.73M | $1.13M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $773K | $1.29M | $533K |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $117.93M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $117.93M | $0 | $0 | $0 | $773K | $1.29M | $533K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $121.22M | $2.41M | $1.82M | $1.14M | $5.31M | $4.01M | $1.66M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $4K | $198 | $1K | $46 | $636 | $636 | $628 |
| Retained Earnings | -$72.82M | -$36.9M | -$24.7M | -$15.38M | -$6.91M | -$4.7M | -$2.09M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $470.74M | $38.21M | $33.83M | $20.93M | $2.23M | $986K | $463K |
| Total Equity | $397.93M | $1.31M | $9.13M | $5.54M | -$4.68M | -$3.72M | -$1.62M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $519.15M | $3.72M | $10.95M | $6.69M | $622K | $295K | $41K |
| Supplementary Data | |||||||
| Total Debt | $0 | $0 | $0 | $0 | $2.17M | $1.85M | $963K |
| Net Debt | -$17.03M | -$3.56M | -$10.94M | -$6.51M | $2.16M | $1.66M | $925K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$35.92M | -$12.2M | -$9.32M | -$8.47M | -$2.21M | -$2.42M | -$1.53M |
| Depreciation & Amortization | $25K | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Income Tax | -$6.19M | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $2.88M | $710K | $832K | $801K | $1.24M | $235K | $92K |
| Changes in Working Capital: | |||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $222K | $181K | -$46K | -$141K | $581K | $307K | $16K |
| Other Working Capital | $764K | $384K | $883K | -$428K | $466K | $747 | $227K |
| Total Working Capital Change | $986K | $565K | $837K | -$569K | $1.05M | $307K | $243K |
| Other Non-Cash Items | $22.09M | $21K | $350K | $1.68M | -$1.17M | $797K | $485K |
| Net Cash from Operating | -$16.13M | -$10.9M | -$7.3M | -$6.56M | -$1.09M | -$1.08M | -$706K |
| Investing Activities | |||||||
| Capital Expenditures | -$77.57M | $0 | $0 | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$77.57M | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Activities | |||||||
| Debt Repaid | $222K | - | - | $15K | -$1.08M | -$1.23M | -$581K |
| Common Stock Issuance | $117.38M | $4.19M | $12.23M | $13.65M | $0 | $0 | $128K |
| Common Stock Repurchases | $0 | $0 | $0 | -$70K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$9.98M | -$662K | -$510K | -$521K | -$179K | $0 | $0 |
| Net Cash from Financing | $107.17M | $3.53M | $11.72M | $13.06M | $899K | $1.23M | $708K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $36K |
| Net Change in Cash | $13.47M | -$7.38M | $4.42M | $6.51M | -$187K | $154K | $38K |
| Supplementary Data | |||||||
| Operating Cash Flow | -$16.13M | -$10.9M | -$7.3M | -$6.56M | -$1.09M | -$1.08M | -$706K |
| Capital Expenditure | $0 | $0 | $0 | $0 | $0 | $0 | $3 |
| Free Cash Flow | -$16.13M | -$10.9M | -$7.3M | -$6.56M | -$1.09M | -$1.08M | -$706K |
| Cash at Beginning | $3.56M | $10.94M | $6.51M | $4K | $192K | $38K | $0 |
| Cash at End | $17.03M | $3.56M | $10.94M | $6.51M | $4K | $192K | $38K |